文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

意大利2000-2014年HIV-1传播性耐药动态及亚型系统发育关系

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

研究分析意大利中北部2000-2014年4323例未治疗HIV-1感染者的蛋白酶/逆转录酶序列,发现非B亚型感染比例从19.5%升至38.5%,传播性耐药总体为8.8%且在非B亚型中从2%升至7.1%,传播簇比例随时间上升且近期耐药传播簇增加,主要涉及非B亚型。

要点

  • 非B亚型感染比例从<2005年的19.5%升至2014年的38.5%,意大利人中从6.5%升至28.8%。
  • 总体传播性耐药为8.8%,非B亚型中从2%升至7.1%(P=0.018)。
  • 传播簇内个体比例在B和非B亚型中均上升,耐药传播簇从14.3%升至35.5%。

核心结论

  • HIV传播流行病学随时间显著变化,传播簇(有时伴耐药)增加提示检测和规范治疗多传播者是控制HIV传播的重要目标。

研究设计与样本

  • 分析意大利中北部2000-2014年诊断的4323例未治疗个体HIV-1蛋白酶/逆转录酶序列,用最大似然和贝叶斯系统发育树定义传播簇。

主要发现

  • 大多数个体为男性(80.2%)和意大利人(72.1%),中位年龄37(IQR 30-45)岁,MSM占42.2%,异性恋者占36.4%。
  • 非B亚型感染占总体30.8%,从<2005年的19.5%增至2014年的38.5%(P<0.0001),意大利人中从6.5%增至28.8%(P<0.0001)。
  • 总体传播性耐药为8.8%,在非B亚型中从2%增至7.1%(P=0.018)。
  • 共识别467个传播簇(涉及1207人,27.9%),传播簇内个体比例在B亚型中从12.9%增至33.5%(P=0.001),非B亚型中从18.4%增至41.9%(P=0.006)。
  • 耐药传播簇占总体簇的13.3%,从14.3%增至35.5%(P=0.005),主要归因于非B亚型感染者,其传播簇中位人数为7(IQR 6-19),高于B亚型的4(IQR 3-4)(P=0.047)。

临床怎么用

  • 应加强HIV传播性耐药监测,尤其关注非B亚型和传播簇的动态变化。
  • 检测和规范治疗多传播者可能是控制HIV传播的关键措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transmitted drug-resistance (TDR) remains a critical aspect for the management of HIV-1-infected individuals. Thus, studying the dynamics of TDR is crucial to optimize HIV care. METHODS: In total, 4323 HIV-1 protease/reverse-transcriptase sequences from drug-naive individuals diagnosed in north and central Italy between 2000 and 2014 were analysed. TDR was evaluated over time. Maximum-likelihood and Bayesian phylogenetic trees with bootstrap and Bayesian-probability supports defined transmission clusters. RESULTS: Most individuals were males (80.2%) and Italian (72.1%), with a median (IQR) age of 37 (30-45) years. MSM accounted for 42.2% of cases, followed by heterosexuals (36.4%). Non-B subtype infections accounted for 30.8% of the overall population and increased over time (<2005-14: 19.5%-38.5%, P < 0.0001), particularly among Italians (<2005-14: 6.5%-28.8%, P < 0.0001). TDR prevalence was 8.8% and increased over time in non-B subtypes (<2005-14: 2%-7.1%, P = 0.018). Overall, 467 transmission clusters (involving 1207 individuals; 27.9%) were identified. The prevalence of individuals grouping in transmission clusters increased over time in both B (<2005-14: 12.9%-33.5%, P = 0.001) and non-B subtypes (<2005-14: 18.4%-41.9%, P = 0.006). TDR transmission clusters were 13.3% within the overall cluster observed and dramatically increased in recent years (<2005-14: 14.3%-35.5%, P = 0.005). This recent increase was mainly due to non-B subtype-infected individuals, who were also more frequently involved in large transmission clusters than those infected with a B subtype [median number of individuals in transmission clusters: 7 (IQR 6-19) versus 4 (3-4), P = 0.047]. CONCLUSIONS: The epidemiology of HIV transmission changed greatly over time; the increasing number of transmission clusters (sometimes with drug resistance) shows that detection and proper treatment of the multi-transmitters is a major target for controlling HIV spread.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Fabeni L, Alteri C, Di Carlo D, et al. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. J Antimicrob Chemother. 2017. PMID: 29091206. doi:10.1093/jac/dkx231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。